ArticleEndoscopic ultrasound
Clinical utility of macroscopic on-site evaluation in EUS-guided tissue acquisition for autoimmune pancreatitis: A retrospective study.
Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Pathological diagnosis of autoimmune pancreatitis (AIP) is essential for selecting the appropriate treatment strategy. Although macroscopic on-site evaluation (MOSE) can reduce the number of needle passes during EUS-guided tissue acquisition (EUS-TA) in pancreatic neoplasms, its utility in AIP remains unclarified. We investigated the utility of MOSE in diagnosing AIP using EUS-TA-derived specimens. Methods: We conducted a retrospective study of patients with type 1 AIP who underwent EUS-TA using fine-needle biopsy needles. Macroscopic visible core (MVC) length was measured using MOSE, and histological diagnosis was evaluated following the International Consensus Diagnostic Criteria. The correlation between MVC length and diagnostic yield, histological features, and tissue volume was assessed. Results: Thirty-eight lesions of 36 patients were included. Among these, 32 had definite AIP and four had probable AIP. Level 1 and 1 or 2 histologies were identified in 47% and 90% of lesions, respectively. Longer MVC length was associated with a higher level 1 histology detection rate ( Conclusion: MVC length ≥22 mm is a practical indicator of adequate tissue quality for the histological diagnosis of AIP. Therefore, MOSE may help determine the number of needle passes during EUS-TA in patients with AIP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.